Illinois · Long-Acting Injectable Buprenorphine
BRIXADI® & SUBLOCADE® Treatment in Illinois
Meet with a DevotedDOc addiction clinician online. If long-acting buprenorphine is right for you, we'll coordinate your treatment so you can receive the injection at a local medical clinic and continue your care through telemedicine.
Compare BRIXADI & SUBLOCADE
How Long-Acting Buprenorphine Care Works
Five steps, two settings. DevotedDOc provides the medical care and the order; an independent local clinic provides the injection.
Step 01
Meet Online
Complete your addiction-medicine visit with DevotedDOc.
Step 02
Build Your Treatment Plan
Your clinician determines whether injectable buprenorphine is appropriate.
Step 03
Coordinate Medication Access
DevotedDOc sends the prescription or order and clinical documentation. The local clinic generally coordinates insurance authorization and medication acquisition.
Step 04
Receive Your Injection Locally
Travel to an independent medical clinic near you.
Step 05
Continue With DevotedDOc
Continue ongoing OUD treatment and follow-up online.
DevotedDOc provides
The addiction-medicine evaluation, OUD treatment planning, telemedicine visits, the BRIXADI or SUBLOCADE prescription or clinical order, required documentation, and longitudinal follow-up.
Independent injection clinics generally provide
Benefits investigation, prior authorization, medication acquisition, scheduling, the physical injection, injection-site monitoring, and administration confirmation.
Independent injection clinics are separate businesses. They are not owned, controlled, staffed, operated or supervised by DevotedDOc.
Long-Acting Buprenorphine
Treatment in Illinois
Buprenorphine is a medication used to treat opioid use disorder. It reduces cravings and withdrawal and is one of the most established treatments for OUD.
Traditional formulations such as films or tablets are usually taken every day. Extended-release formulations release buprenorphine over a longer period, which removes the daily dosing routine and the need to keep medication at home.
BRIXADI and SUBLOCADE are both extended-release buprenorphine formulations. Both are administered by a healthcare professional rather than self-injected. Whether either one is a good fit depends on your history, your current medication, and your clinical picture — that determination is made by your clinician.
BRIXADI®
Weekly and monthly long-acting buprenorphine options
BRIXADI is given as an injection under the skin on either a weekly or a monthly schedule, which gives your clinician more than one dosing rhythm to work with. It is administered by a healthcare professional at a clinic.
SUBLOCADE®
Monthly extended-release buprenorphine
SUBLOCADE is given as a monthly injection administered by a healthcare professional. One appointment a month covers your buprenorphine dosing for that month.
Find BRIXADI
Injection Access in Illinois
Select a city to see where BRIXADI administration is available. The locations below represent Illinois cities and communities with pharmacies contracted to administer BRIXADI.
Shading reflects statewide BRIXADI administration access through contracted pharmacies. Shaded coverage does not guarantee access at every individual pharmacy location.
Statewide access · contracted administering pharmacies
Illinois
Statewide BRIXADI injection access through contracted administering pharmacies.
Availability should be confirmed with the administering pharmacy before scheduling.
Insurance and payer information is not provided in the Braeburn injection-site document. Coverage should be confirmed with the administering pharmacy and the patient’s health plan.
Access verified: September 2026
Source: Braeburn Inc. — Pharmacies Contracted to Administer BRIXADI, September 2026
Illinois Injection Locations
Confirmed injection access, in text. Each confirmed city or market can link to its local treatment page.
Illinois
BRIXADI administration access
Complete your DevotedDOc appointment online and receive your injection locally through a participating Illinois clinic or healthcare administration site. Confirmed BRIXADI treatment and administration access is available across the Chicago area and additional communities in northern and central Illinois.
Contact Us for Injection Site AddressInjection Sites in Illinois
Northbrook / North Shore
Active BRIXADI administration access. Serves Northbrook, Arlington Heights, Des Plaines, Evanston, Park Ridge, Waukegan and surrounding communities.
Tinley Park / South Chicagoland
Active BRIXADI administration access. Serves Tinley Park, Orland Park, Joliet, Bolingbrook, Chicago and surrounding communities.
North Aurora / Western Suburbs
Active BRIXADI administration access. Serves North Aurora, Naperville, Elgin, St. Charles, DeKalb and surrounding communities.
Rockford / Belvidere
Active BRIXADI administration access. Serves Rockford, Belvidere, Rochelle and surrounding northern Illinois communities.
Peoria / Washington
Active BRIXADI administration access. Serves Peoria, Washington, Bloomington-Normal, Pekin, Galesburg and surrounding central Illinois communities.
Additional BRIXADI administration options may be available in other Illinois communities.
Only city-level location information is displayed publicly on this page. Your DevotedDOc care team can help identify an appropriate participating administration site and provide the specific address when coordinating your injection appointment.
Network expansion markets
DevotedDOc is actively developing local injection access in these Illinois markets. There is no confirmed injection location in these cities on the current Illinois access list, and no clinic marker should appear on the map until access is verified.
Springfield
In development — Central IllinoisChampaign / Urbana
In development — East-Central IllinoisCarbondale
In development — Southern IllinoisMarkets under evaluation, with no confirmed access and no announced timeline: Decatur, Quincy, Danville, Kankakee, Mattoon and additional underserved Illinois communities.
Illinois has an established BRIXADI injection network
DevotedDOc patients can access BRIXADI administration through participating clinics and healthcare locations across the Chicago metropolitan area, northern Illinois and central Illinois. The current Illinois network includes confirmed administration options in several major population centers as well as surrounding communities.
Your DevotedDOc care team can coordinate with an appropriate participating location based on where you live, medication availability, insurance participation and scheduling.
View Illinois Treatment & Injection OptionsMedications Available
BRIXADI weekly and BRIXADI monthly
Insurance
Insurance participation and coverage vary by administration location and health plan. DevotedDOc can help verify coverage, prior-authorization requirements and coordinate with an appropriate participating site before your injection appointment.
Communities Served
Chicago, Northbrook, Arlington Heights, Des Plaines, Evanston, Tinley Park, Orland Park, Joliet, North Aurora, Naperville, Elgin, Rockford, Belvidere, Peoria, Washington and additional Illinois communities.
Does Insurance Cover BRIXADI
or SUBLOCADE in Illinois?
Coverage varies by health plan, medication and administration location. Commercial insurance, Medicare and Illinois Medicaid may provide coverage for extended-release buprenorphine. Prior authorization, billing requirements and patient cost-sharing can vary, so benefits should be verified before an injection is scheduled.
How coverage generally works in Illinois. Not a guarantee of coverage or payment.
| Coverage Type | What to Expect |
|---|---|
|
Commercial insurance
|
BRIXADI and SUBLOCADE may be covered under a patient's pharmacy or medical benefit, depending on the plan and administration site. Prior authorization or other utilization requirements may apply. Manufacturer copay-savings programs are available for some eligible commercially insured patients; patients enrolled in government-funded insurance programs are generally not eligible for those copay programs. |
|
Medicare & Medicare Advantage
|
Coverage depends on the patient's specific Medicare benefits, the medication and how the administering location bills for it. The receiving location should verify benefits, patient cost-sharing and any authorization requirements before scheduling. |
|
Illinois Medicaid
|
Both BRIXADI and SUBLOCADE are listed as preferred substance use disorder medications on the Illinois Medicaid Preferred Drug List effective July 27, 2026. Coverage can still depend on eligibility, the benefit pathway, administration-site participation and applicable billing or authorization requirements, so each patient's benefits should be verified before treatment. |
|
Self-pay
|
Cash pricing varies by administration location. Patients should request an estimate for both the medication and administration before scheduling. Manufacturer patient-support resources may also be available depending on eligibility. |
Medication coverage and administration-site participation are two different things
A medication may be covered by your health plan even when a particular Illinois clinic, pharmacy or injection site does not participate with that plan or cannot bill your specific benefit. DevotedDOc and the receiving administration site verify the applicable access pathway before treatment is scheduled.
If you have Illinois Medicaid
BRIXADI and SUBLOCADE may be covered through Illinois Medicaid depending on your eligibility, plan requirements and how the medication is supplied and billed. However, not every participating administration site accepts Illinois Medicaid or every Medicaid managed care plan, and some locations may not be able to bill both the medication and administration through the same benefit.
If you have Illinois Medicaid, contact DevotedDOc and we'll help you understand the available options and identify an appropriate administration pathway when available.
Medication coverage through Illinois Medicaid does not mean statewide injection access. Injection availability depends on medication availability, the administration site's participation with your plan and any applicable authorization or billing requirements.
Coverage information is educational and is not a guarantee of benefits, authorization or payment. Plan requirements and administration-site participation can change. Your benefits and applicable access requirements are verified before an injection is scheduled.
Why BRIXADI and SUBLOCADE Are Given by a Healthcare Professional
These are provider-administered medications. They are not dispensed to patients for self-injection, and patients do not take the medication home to administer themselves.
Both medications are subject to special distribution and administration requirements. The medication is supplied to an authorized healthcare setting or participating administration site, and a qualified healthcare professional gives the injection.
That is why the Illinois model has two parts. A participating pharmacy, clinic or other authorized administration site handles the physical injection. DevotedDOc maintains the clinical treatment relationship — your evaluation, treatment plan, medication decisions and follow-up care.
It also means you do not have to manage the medication-supply process on your own. Depending on the location and insurance pathway, the receiving administration site may help coordinate benefits verification, prior authorization, medication acquisition and injection scheduling before your appointment.
Can I Start Buprenorphine Treatment Online in Illinois?
DevotedDOc's Illinois-licensed clinicians can evaluate Illinois patients for buprenorphine treatment through secure telehealth visits, consistent with current federal and state requirements.
Start Your Online EvaluationEvaluation
A Illinois-licensed clinician reviews your history, your current medications and your treatment goals.
Treatment plan
You and your clinician decide on an appropriate treatment approach together.
Medication selection
Daily buprenorphine, BRIXADI or SUBLOCADE, based on your clinical needs, insurance coverage and available local administration options.
Injection coordination, if appropriate
DevotedDOc sends the necessary prescription or order and clinical documentation to a participating Illinois administration site.
Ongoing follow-up
Telemedicine visits continue between injections to monitor cravings, side effects, medication response and ongoing recovery care.
Can I Switch From Suboxone® or Daily Buprenorphine to an Injection in Illinois?
Many patients already taking daily buprenorphine may be candidates for a long-acting injection. It is one of the most common reasons patients explore BRIXADI or SUBLOCADE treatment with DevotedDOc.
Talk With an Addiction ClinicianBRIXADI and SUBLOCADE have different initiation requirements, including considerations related to your current buprenorphine treatment and clinical history.
Whether and when you stop taking daily films or tablets depends on the medication you and your clinician choose and your individualized treatment plan.
The transition depends on several clinical factors — including your current dose, treatment history, other medications and response to buprenorphine.
Your DevotedDOc clinician builds the transition plan with you. We do not provide individualized dosing instructions online, and you should not change or stop your medication without guidance from your treating clinician.
Looking for a Long-Acting Treatment Option for Alcohol Use Disorder in Illinois?
DevotedDOc also provides evaluation and ongoing treatment for alcohol use disorder, including extended-release naltrexone (Vivitrol®) when clinically appropriate.
Like long-acting buprenorphine, Vivitrol is administered by a healthcare professional at a local Illinois administration site, while DevotedDOc can provide the clinical evaluation, treatment planning and ongoing follow-up through telemedicine.
Illinois BRIXADI & SUBLOCADE FAQs
Medical review & sources
This page is educational and is not a substitute for medical advice, diagnosis or treatment. It does not provide individualized dosing guidance. Talk with a licensed clinician about your own care. If you are in crisis, call 911 or call or text 988.
U.S. Food and Drug Administration — FDA-approved prescribing information and REMS materials for BRIXADI (buprenorphine extended-release injection) and SUBLOCADE (buprenorphine extended-release injection), including requirements governing restricted distribution and administration by healthcare professionals.
Illinois Department of Healthcare and Family Services — Illinois Medicaid Preferred Drug List, effective July 27, 2026. BRIXADI and SUBLOCADE are listed as preferred medications within the Substance Use Disorder Agents category.
SAMHSA — buprenorphine and medications for opioid use disorder treatment guidance, provider resources and FindTreatment.gov.
DEA and HHS — federal telemedicine prescribing requirements for controlled substances and the current temporary telemedicine flexibilities extended through December 31, 2026.
Manufacturer prescribing, access and patient-support materials for BRIXADI (Braeburn) and SUBLOCADE (Indivior/INSUPPORT).
Ready to Explore Long-Acting Buprenorphine?
Start with an online addiction-medicine visit. Your DevotedDOc clinician can help determine whether BRIXADI, SUBLOCADE, daily buprenorphine, or another treatment approach is appropriate for you.